Shalini Sharp
2014 - Ultragenyx Pharmaceutical
In 2014, Shalini Sharp earned a total compensation of $512.1K as Chief Financial Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 18% decrease compared to previous year.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Non-Equity Incentive Plan | $117,563 |
| Salary | $350,000 |
| Other | $14,500 |
| Total | $512,063 |
Sharp received $350K in salary, accounting for 68% of the total pay in 2014.
Sharp also received $30K in bonus, $117.6K in non-equity incentive plan and $14.5K in other compensation.
Rankings
In 2014, Shalini Sharp's compensation ranked 10,190th out of 13,032 executives tracked by ExecPay. In other words, Sharp earned more than 21.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,190 out of 13,032 | 22nd |
Division Manufacturing | 3,870 out of 4,966 | 22nd |
Major group Chemicals And Allied Products | 1,327 out of 1,686 | 21st |
Industry group Drugs | 1,060 out of 1,365 | 22nd |
Industry Pharmaceutical Preparations | 815 out of 1,043 | 22nd |
Source: SEC filing on April 28, 2017.
Sharp's colleagues
We found three more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2014.